Exp Clin Endocrinol Diabetes 2023; 131(06): 375-376
DOI: 10.1055/a-2075-0735
Letter to the Editor

The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?

David M Williams
1   Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL
,
Ayesha Shaikh
1   Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL
,
Ellen Williams
2   Department of Acute Medicine, Morriston Hospital, Swansea, SA6 6NL
,
Aiman Maroof
2   Department of Acute Medicine, Morriston Hospital, Swansea, SA6 6NL
,
Therese Michael
3   Department of Laboratory Medicine, Morriston Hospital, Swansea, SA6 6NL
,
Kusuma Boregowda
1   Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL
› Author Affiliations


Publication History

Article published online:
09 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Asbach E, Kellnar A, Bekeran M. et al. Prevalence of primary aldosteronism in newly diagnosed hypertensive patients in primary care. Exp Clin Endocrinol Diabetes 2022; 130: 801-805
  • 2 Funder JW, Carey RM, Mantero F. et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2016; 101: 1889-1916
  • 3 Lonati C, Bassani N, Gritti A. et al. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. J Hypertens 2014; 32: 627-634
  • 4 Buffolo F, Monticone S, Burrello J. et al. Is primary aldosteronism still largely unrecognized?. Horm Metab Res 2017; 49: 908-914